In AD, different models have been tested: amyloid metabolism (APP/PS1) [39,161,162,163,164,165,166], senescence models (SAMP8) [40,167], and triple mutations (APP, MAPT, PSEN1) [168,169,170]. Here, MAPT is linked to Alzheimer disease.